ULTIMUM™ 407832Recalls & reported problems
St. Jude Medical, Inc. · Hemostasis Introducer · Class 2
- Adverse event reports
- 9
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 05414734008822), received between Feb 15, 2019 and Mar 21, 2024 — classified as 9 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (7 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Fluid/Blood Leak7
- Adverse Event Without Identified Device or Use Problem1
- Gas/Air Leak1
Patient problems
- No Clinical Signs, Symptoms or Conditions8
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 21, 2024Fluid/Blood Leak; Fluid/Blood Leak
DURING THE RIGHT LEG PERIPHERAL ARTERIAL OCCLUSION DISEASE, PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PAOD PTA) SURGERY, A FLUID LEAK OCCURRED. THE SHEATH WAS INSERTED INTO THE PATIENT'S LEFT FEMORAL ARTERY. WHILE FLUSHING WITH NORMAL SALINE, IT WAS OBSERVED THAT THE HEMOSTASIS VALVE OF THE SHEATH WAS LEAKING. THE DEVICE WAS EXCHANGED AND THE PROCEDURE WAS COMPLETED WITH NO ADVERSE CONSEQUENCE TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18950496 ↗MalfunctionFeb 5, 2024Fluid/Blood Leak; Fluid/Blood Leak
DURING A VASCULAR ANGIOPLASTY PROCEDURE, BLOOD LEAKED FROM THE HEMOSTASIS VALVE. THE DEVICE WAS EXCHANGED, AND THE PROCEDURE WAS COMPLETED WITH NO ADVERSE PATIENT CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18646596 ↗MalfunctionMar 27, 2023Fluid/Blood Leak; Fluid/Blood Leak
RELATED MANUFACTURING REF: 3005334138-2023-00122. DURING THE PERCUTANEOUS TRANSLUMINAL AORTIC VALVULOPLASTY (PTAV) PROCEDURE, BLOOD LEAKS OCCURRED WITH THE VALVE ON TWO SHEATHS. AFTER PUNCTURE IN THE ANTEBRACHIAL VEIN, THE PHYSICIAN FOUND THE VALVE WAS LEAKING BLOOD. THE SHEATH WAS THEN REPLACED, BUT THE SECOND SHEATH HAD THE SAME ISSUE. THE PHYSICIAN THOUGHT THE SITUATION WAS BETTER THAN WITH THE FIRST SHEATH AND SO IT WAS USED TO COMPLETE THE PROCEDURE WITH NO ADVERSE PATIENT CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16624590 ↗MalfunctionMar 27, 2023Fluid/Blood Leak; Fluid/Blood Leak
RELATED MANUFACTURING REF: 3005334138-2023-00123. DURING THE PERCUTANEOUS TRANSLUMINAL AORTIC VALVULOPLASTY (PTAV) PROCEDURE, BLOOD LEAKS OCCURRED WITH THE VALVE ON TWO SHEATHS. AFTER PUNCTURE IN THE ANTEBRACHIAL VEIN, THE PHYSICIAN FOUND THE VALVE WAS LEAKING BLOOD. THE SHEATH WAS THEN REPLACED, BUT THE SECOND SHEATH HAD THE SAME ISSUE. THE PHYSICIAN THOUGHT THE SITUATION WAS BETTER THAN WITH THE FIRST SHEATH AND SO IT WAS USED TO COMPLETE THE PROCEDURE WITH NO ADVERSE PATIENT CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16624587 ↗MalfunctionMar 16, 2023Fluid/Blood Leak; Fluid/Blood Leak
DURING THE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PROCEDURE, THE PHYSICIAN INSERTED THE SHEATH INTO THE FEMORAL VEIN, AND A BLOOD LEAK WAS NOTED AT THE VALVE. THE PHYSICIAN REPLACED THE SHEATH TO COMPLETE THE PROCEDURE WITH NO ADVERSE CONSEQUENCE TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16551005 ↗MalfunctionNov 22, 2022Fluid/Blood Leak; Fluid/Blood Leak
DURING THE PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) PROCEDURE, THE INTRODUCER VALVE HAD A BLOOD LEAK. PROCEDURE WAS COMPLETED WITHOUT EXCHANGING THE INTRODUCER AND THERE WERE NO ADVERSE HEALTH CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15848573 ↗MalfunctionNov 4, 2022Gas/Air Leak; Gas/Air Leak
DURING THE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY PROCEDURE, THERE WAS AN AIR LEAK FROM THE INTRODUCER. THE DOCTOR USED A SYRINGE TO ASPIRATE BUT FOUND AIR DRAWN FROM THE TUBE AFTER LIMITED BLOOD RETURN. THE INTRODUCER WAS REPLACED AND THE PROCEDURE WAS COMPLETED WITH NO ADVERSE CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15736329 ↗MalfunctionOct 24, 2022Fluid/Blood Leak; Fluid/Blood Leak
DURING A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY SURGERY, A BLOOK LEAK WAS NOTED AT THE VALVE (REGARDLESS OF USE OF A GUIDEWIRE). ANOTHER SHEATH WAS GOING TO BE USED, HOWEVER, THE PATIENT'S VESSEL WAS NOT AVAILABLE TO INSERT A DEVICE AGAIN, SO HE DECIDED TO CONTINUE THE SURGERY WHILE THE PATIENT WAS STILL BLEEDING. THE PROCEDURE WAS COMPLETED WITH NO CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15658122 ↗MalfunctionFeb 15, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING THE PROCEDURE, THE HUB OF THE ULTIMUM HEMOSTASIS INTRODUCER CAME APART.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8346300 ↗
Other INTRODUCER, CATHETER devices
- VIZIGO D138502Biosense Webster Inc · INTRODUCER, CATHETER2 recalls4 deaths2,839 reports
- VIZIGO D138501Biosense Webster Inc · INTRODUCER, CATHETER2 recalls2 deaths2,005 reports
- Swartz™ 407451St. Jude Medical, Inc. · INTRODUCER, CATHETER5 deaths728 reports
- Edwards eSheath+ Introducer set 914ESPEdwards Lifesciences LLC · Introducer, Catheter22 deaths532 reports
- Fast-Cath™ 406849St. Jude Medical, Inc. · INTRODUCER, CATHETER420 reports
- VIZIGO D138503Biosense Webster Inc · INTRODUCER, CATHETER362 reports
- Agilis™ G408318St. Jude Medical, Inc. · INTRODUCER, CATHETER333 reports
- Agilis™ NxT Steerable Introducer Dual-Reach™ SI-1371-MSt. Jude Medical, Inc. · Introducer, catheter1 death301 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.